- Report
- May 2023
- 140 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- April 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- October 2023
- 145 Pages
Global
From €3129EUR$3,150USD£2,602GBP
- Report
- September 2022
- 30 Pages
Global
From €1937EUR$1,950USD£1,611GBP
- Report
- November 2022
- 82 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Report
- March 2021
- 214 Pages
Global
From €10923EUR$10,995USD£9,082GBP
- Report
- August 2022
United States
From €1927EUR$1,940USD£1,602GBP
- Report
- August 2022
Global
From €1182EUR$1,190USD£983GBP
- Report
- February 2022
- 42 Pages
Global
From €3477EUR$3,500USD£2,891GBP
- Report
- September 2024
- 69 Pages
China
From €1788EUR$1,800USD£1,487GBP
- Report
- September 2024
- 239 Pages
China
From €3974EUR$4,000USD£3,304GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Report
- October 2024
- 81 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- January 2024
- 77 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- September 2023
- 115 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- August 2023
- 78 Pages
Global
From €3500EUR$3,774USD£3,012GBP
The Liver Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat liver cancer. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells. Immunotherapy is a type of drug that works by stimulating the body's own immune system to fight cancer.
The Liver Cancer Drugs market is highly competitive, with many companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly developing new drugs and treatments to improve the quality of life for those affected by liver cancer. Show Less Read more